NCT03769896
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Department of Neurology - Medical University Innsbruck Innsbruck, Tyrol, Austria
Clinical trial condition
Parkinsonian Disorders
Explore clinical trials studying Parkinsonian Disorders. Study availability and eligibility vary by location and protocol.
3,334 public trials
610 recruiting studies
Parkinsonian Disorders trial results
NCT02458430
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- University of Michigan Health System Functional Neuroimaging, Cognitive and Mobility Laboratory Ann Arbor, Michigan, United States
NCT03773796
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Department of Neurology - Medical University Innsbruck Innsbruck, Tyrol, Austria
NCT02649608
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- US1251 Hallandale, Florida, United States
- US1126 Orlando, Florida, United States
- US1352 Chicago, Illinois, United States
- US1084 Detroit, Michigan, United States
Completed
Dental Appliance for Parkinson's Disease
NCT04082663
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Washington University School of Medicine Program in Physical Therapy St Louis, Missouri, United States
Completed
Cognitive Rehabilitation for PD
NCT03335150
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- VA San Diego Healthcare System, San Diego, CA San Diego, California, United States
NCT02939534
- Conditions
- Autoimmune Diseases, Basal Ganglia Diseases, Brain Diseases, +9 more
- Locations
-
- University of California San Diego School of Medicine La Jolla, California, United States
- Shirley Ryan Ability Lab Chicago, Illinois, United States
- Columbia University Medical Center New York, United States
Completed
A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects
NCT01171313
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- XenoPort Clinical Site Phoenix, Arizona, United States
- XenoPort Clinical Site Little Rock, Arkansas, United States
- XenoPort Clinical Site Long Beach, California, United States
- XenoPort Clinical Site Sunnyvale, California, United States
NCT03827746
- Conditions
- Anxiety Disorders, Balance, Basal Ganglia Diseases, +15 more
- Locations
-
- Marmara University Istanbul, Turkey (Türkiye)
NCT03845387
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Research Site Multiple Locations, Japan